Agilent Technologies Current Ratio 2010-2025 | A
Current and historical current ratio for Agilent Technologies (A) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Agilent Technologies current ratio for the three months ending January 31, 2025 was 2.20.
| Agilent Technologies Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-01-31 | $4.11B | $1.87B | 2.20 |
| 2024-10-31 | $3.96B | $1.90B | 2.09 |
| 2024-07-31 | $4.26B | $2.39B | 1.78 |
| 2024-04-30 | $4.20B | $1.96B | 2.15 |
| 2024-01-31 | $4.34B | $1.62B | 2.68 |
| 2023-10-31 | $4.19B | $1.60B | 2.61 |
| 2023-07-31 | $4.03B | $1.76B | 2.29 |
| 2023-04-30 | $3.95B | $1.67B | 2.37 |
| 2023-01-31 | $4.08B | $1.94B | 2.11 |
| 2022-10-31 | $3.78B | $1.86B | 2.03 |
| 2022-07-31 | $3.69B | $1.90B | 1.94 |
| 2022-04-30 | $3.64B | $1.81B | 2.01 |
| 2022-01-31 | $3.47B | $1.58B | 2.19 |
| 2021-10-31 | $3.80B | $1.71B | 2.22 |
| 2021-07-31 | $3.63B | $1.72B | 2.11 |
| 2021-04-30 | $3.51B | $1.76B | 2.00 |
| 2021-01-31 | $3.48B | $1.69B | 2.07 |
| 2020-10-31 | $3.42B | $1.47B | 2.33 |
| 2020-07-31 | $3.25B | $1.31B | 2.47 |
| 2020-04-30 | $3.17B | $1.95B | 1.63 |
| 2020-01-31 | $3.10B | $1.89B | 1.64 |
| 2019-10-31 | $3.19B | $2.08B | 1.53 |
| 2019-07-31 | $3.46B | $1.62B | 2.13 |
| 2019-04-30 | $3.81B | $1.12B | 3.41 |
| 2019-01-31 | $3.71B | $1.10B | 3.39 |
| 2018-10-31 | $3.85B | $1.17B | 3.29 |
| 2018-07-31 | $3.67B | $1.01B | 3.62 |
| 2018-04-30 | $4.53B | $1.37B | 3.32 |
| 2018-01-31 | $4.40B | $1.36B | 3.23 |
| 2017-10-31 | $4.17B | $1.26B | 3.30 |
| 2017-07-31 | $4.00B | $1.24B | 3.22 |
| 2017-04-30 | $3.80B | $1.19B | 3.20 |
| 2017-01-31 | $3.64B | $1.09B | 3.34 |
| 2016-10-31 | $3.64B | $0.95B | 3.85 |
| 2016-07-31 | $3.53B | $1.15B | 3.07 |
| 2016-04-30 | $3.49B | $1.13B | 3.08 |
| 2016-01-31 | $3.40B | $0.95B | 3.59 |
| 2015-10-31 | $3.69B | $0.98B | 3.78 |
| 2015-07-31 | $3.48B | $0.85B | 4.08 |
| 2015-04-30 | $3.62B | $0.93B | 3.89 |
| 2015-01-31 | $3.65B | $0.93B | 3.94 |
| 2014-10-31 | $5.51B | $1.69B | 3.26 |
| 2014-07-31 | $4.83B | $1.58B | 3.06 |
| 2014-04-30 | $5.38B | $1.72B | 3.13 |
| 2014-01-31 | $5.07B | $1.55B | 3.28 |
| 2013-10-31 | $4.98B | $1.60B | 3.11 |
| 2013-07-31 | $4.58B | $1.55B | 2.96 |
| 2013-04-30 | $4.82B | $1.91B | 2.53 |
| 2013-01-31 | $4.71B | $1.85B | 2.55 |
| 2012-10-31 | $4.63B | $1.89B | 2.45 |
| 2012-07-31 | $4.21B | $2.09B | 2.02 |
| 2012-04-30 | $6.01B | $1.84B | 3.28 |
| 2012-01-31 | $5.72B | $1.71B | 3.35 |
| 2011-10-31 | $5.57B | $1.84B | 3.03 |
| 2011-07-31 | $5.22B | $1.51B | 3.47 |
| 2011-04-30 | $5.10B | $1.59B | 3.20 |
| 2011-01-31 | $4.60B | $1.41B | 3.27 |
| 2010-10-31 | $6.17B | $3.08B | 2.00 |
| 2010-07-31 | $5.74B | $2.92B | 1.97 |
| 2010-04-30 | $5.71B | $2.71B | 2.11 |
| 2010-01-31 | $5.52B | $2.55B | 2.17 |
| 2009-10-31 | $3.96B | $1.12B | 3.53 |
| 2009-07-31 | $2.90B | $0.99B | 2.92 |
| 2009-04-30 | $2.88B | $1.10B | 2.62 |
| 2009-01-31 | $3.01B | $1.13B | 2.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $31.721B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.294B | 27.81 |
| Boston Scientific (BSX) | United States | $157.073B | 39.32 |
| Stryker (SYK) | United States | $146.485B | 30.63 |
| EssilorLuxottica (ESLOY) | France | $131.510B | 0.00 |
| Medtronic (MDT) | Ireland | $104.117B | 14.76 |
| Haleon (HLN) | United Kingdom | $50.587B | 28.80 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.544B | 0.00 |
| ResMed (RMD) | United States | $36.103B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $32.514B | 15.44 |
| Terumo (TRUMY) | Japan | $28.131B | 36.54 |
| Insulet (PODD) | United States | $22.987B | 90.23 |
| Koninklijke Philips (PHG) | Netherlands | $21.694B | 15.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.639B | 11.97 |
| Baxter (BAX) | United States | $15.842B | 11.83 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.666B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.269B | 21.81 |
| Lantheus Holdings (LNTH) | United States | $5.242B | 13.22 |
| Prestige Consumer Healthcare (PBH) | United States | $4.244B | 18.96 |
| Perrigo (PRGO) | Ireland | $3.757B | 9.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.266B | 14.88 |
| ICU Medical (ICUI) | United States | $3.210B | 23.67 |
| Envista Holdings (NVST) | United States | $3.051B | 25.35 |
| GN Store Nord (GNNDY) | Denmark | $2.163B | 17.92 |
| QuidelOrtho (QDEL) | United States | $2.114B | 14.54 |
| LeMaitre Vascular (LMAT) | United States | $1.868B | 41.76 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Neogen (NEOG) | United States | $1.335B | 17.08 |
| Acuren (TIC) | United States | $1.317B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.256B | 12.75 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| CeriBell (CBLL) | United States | $0.625B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.590B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Owens & Minor (OMI) | United States | $0.509B | 4.22 |
| Capricor Therapeutics (CAPR) | United States | $0.479B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.446B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.307B | 54.70 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.11 |
| Cerus (CERS) | United States | $0.241B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| Quanterix (QTRX) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.46 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.69 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Agape ATP (ATPC) | $0.092B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.42 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.47 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.86 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |